We prospectively studied 47 sarcoidosis suspects and compared conjunctival and transbronchial lung biopsies in these patients.
biopsy was positive in 31 patients, and the conjunctival was positive in 19 . The transbronchial lung biopsy was more likely to be positive in black patients (p=0009) and in patients with pulmonary infiltrates on chest x ray (p=00044). In comparison, the conjunctival biopsy was more likely to be positive in patients with conjunctival follicles (p=0036), ocular abnormalities consistent with sarcoidosis (p=0.02), and in patients with pulmonary infiltrates on chest x ray (p=0029). Iritis was present in 12 (PPD) and an anergy panel, and none of these patients had a positive reaction to the tuberculin antigen. Each patient had chest x rays, and these x rays were graded into four stages according to conventional methods. 18 Stage 0 is normal, and stage 1 has bilateral hilar adenopathy. Stage 2 has enlarged hilar nodes with pulmonary opacities, and stage 3 has pulmonary infiltrates without node enlargement. Every patient had function tests (PFT). For our analysis we examined the forced vital capacity, forced expiratory volume in 1 second, forced expiratory flow, 25-75% maximum voluntary ventilation, and total lung capacity. Each subtest was considered abnormal if it was less than 75% of the predicted value for patients the same age, sex and size.
Each sarcoidosis suspect was examined by a chest specialist, who obtained at least six and usually eight to 10 random transbronchial biopsies from each patient with a fibreoptic bronchoscope. We obtained angiotensin converting enzyme (ACE) levels in 29 patients. Every patient had a complete ocular examination by an ophthalmologist. A strip of conjunctiva 10 to 12 mm long was excised from each eye, and any conjunctival abnormality noted on slit-lamp examination was included in the biopsy when possible. The biopsy specimens were fixed in formalin and embedded in paraffin blocks, were sectioned (Fig 1) , and stained with haematoxylin and eosin. If a biopsy showed non-caseating granulomas, it was stained for fungal and acid fast organisms. If no organisms were present, the biopsy was considered to be positive for sarcoidosis (Fig 2) .
History, physical and ocular findings, PFT results, ACE levels, chest x ray stage, and biopsy findings of the 47 patients were entered on to a form adapted for use with a computer database. The data were evaluated with the help of descriptive statistics and, for frequency data, Fisher's exact test of probability. For Transbronchial biopsies were positive in 77-1% and conjunctival biopsies in 45-7% of black sarcoidosis suspects. Caucasian sarcoidosis suspects had 33 3% and 25% positive TBBX and CBX respectively. The difference between the two races was significant for the TBBX (p= 0 009) but not for the conjunctival biopsy (p= 0 18). Patients with pulmonary infiltrates had a positive TBBX 80-6% of the time, while 37 5% of patients with no pulmonary infiltrates had a positive biopsy (p=00044). Likewise, the conjunctival biopsy was more likely to be positive in patients with pulmonary infiltrates than patients without infiltrates, 51 6% versus 23 1% (p= 0029). Conjunctival biopsies were positive more often in sarcoidosis suspects with follicles, 66 7%, than those with a normal conjunctiva 31-4% (p= 0 036). Conjunctival biopsies were positive in 60% ofthose with any eye abnormality consistent with sarcoidosis compared with 25-9% of those with no abnormalities on ocular examination (p=0 02). We could find no element of the PFT, singly or in combination, that correlated with a positive TBBX or CBX.
The diagnosis of sarcoidosis was established in 10 of the 12 suspects with conjunctival follicles, and the conjunctival biopsy detected 8 (80%) of these. Any ocular abnormality consistent with sarcoidosis was found in 20, and 18 were eventually found to have sarcoidosis. The conjunctival biopsy detected 12 of these (66%).
The ACE test was abnormal in 62% of those with positive biopsies. Black patients, patients with intraocular inflammation, or patients with more advanced chest x ray stages were not more likely to have an abnormal ACE test.
Discussion
More than one-half of the sarcoidosis patients (54 1%) had some type of ocular abnormality, and 32-4% had intraocular inflammation. These values are greater than in previous studies being 34% and 28% respectively. The previous investigations were retrospective studies from sarcoidosis centres, and it was difficult to determine if the patients were being treated for sarcoidosis at the time of their ocular examination. We Biopsy Site: Inferior Fornix Figure 1 : The conjunctival biopsy was taken from the inferiorfornix. The specimen was sectioned at three levels for histopathologic evaluation.
Conjunctival biopsy in the diagnosis ofsarcoidosis performed a prospective study of untreated patients. All our patients were examined by an ophthalmologist in contrast to some ofthe studies where only selected patients were examined by an ophthalmologist. Because of our findings we would strongly recommend early ophthalmic consultation for every sarcoidosis patient.
The conjunctival biopsy was positive in 40 4% of suspects. Again, this number is hard to compare with previous reports. Past studies frequently included patients with known sarcoidosis, included biopsies only in patients with' or without' conjunctival abnormalities, and had large variations of the biopsy size." Our biopsy size was consistent from patient to patient and larger than in many of the studies. In past studies the range of positive conjunctival biopsies ranged from 0 to 75%, with a weighted average of 24%. In our study conjunctival biopsies were positive in 66-7% with and 31-4% without conjunctival follicles. Thus we found blind biopsies can be useful in the diagnosis of sarcoidosis, which is in contrast to previous studies that have reported blind conjunctival biopsies being valueless. '1 Although our study did not have any control patients, three previous studies have addressed the incidence of false positive conjunctival biopsies." 1214 The total number of control conjunctival biopsies in these three studies was 116, and many of these patients had other granulomatous disorders. There were no false positives. In our study and in the previous studies, '-17 no serious complications have been reported from conjunctival biopsy.
Angiotensin converting enzyme has been used to help make the diagnosis of sarcoidosis, but there are two problems with using the ACE test. The first is its low sensitivity. The second is that every disease that would be included in a differential diagnosis with sarcoidosis can also cause a rise in ACE levels.2324 Although the histological picture of sarcoidosis -non-caseating granulomas -is not pathognomonic, histopathological examination of tissue provides information that helps to discriminate between the elements in the differential diagnosis of sarcoidosis, something the ACE test does not do efficiently.
We found biopsy of the conjunctiva to be an effective and useful method of obtaining this histopathological information, and it seemed particularly worthwhile in patients with advanced chest x ray stages or ocular abnormalities. Transbronchial lung biopsy is expensive and invasive, and carries a greater risk of serious complication than conjunctival biopsy. A practical biopsy strategy would be to biopsy the conjunctiva of sarcoidosis suspects and, only if the conjunctival biopsy is negative, do a transbronchial lung biopsy. Limiting the conjunctival biopsy to those patients with ocular abnormalities or advanced chest x ray stages might prove to be even more cost effective.
